Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism MALT1 inhibitors(Mucosa-associated lymphoid tissue lymphoma translocation protein 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hematologic Neoplasms | Preclinical | US | Triplet Therapeutics, Inc.Startup | 01 Apr 2024 |
Hematologic Neoplasms | Preclinical | US | 01 Apr 2024 |